ZyVersa Therapeutics, Inc.
ZVSA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001859007
No open-market purchases or sales by ZyVersa Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding ZyVersa Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 11 | 12 | +1 |
| Shares | 297.1K | 1.24M | +938.8K (+316.0%) |
| Value | $73.4K | $161.8K | +$88.4K (+120.5%) |
New holders (6)
Institutions that held ZyVersa Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 980,568 | $128.5K | 0.00% |
| Geode Capital Management, LLC | 123,130 | $16.1K | 0.00% |
| XTX Topco Ltd | 16,709 | $2.19K | 0.00% |
| Millennium Management LLC | 15,190 | $1.99K | 0.00% |
| Susquehanna International Group, LLP | 13,537 | $1.77K | 0.00% |
| UBS Group AG | 107 | $14 | 0.00% |
Sold out (5)
Institutions that held ZyVersa Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Virtu Financial LLC | 120,377 | $30.0K |
| Two Sigma Securities, LLC | 39,498 | $9.70K |
| Cubist Systematic Strategies, LLC | 36,870 | $9.05K |
| StoneX Group Inc. | 12,700 | $3.12K |
| Barclays PLC | 1,100 | $270 |